Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Cardio.AI® logo — AI-powered platform for high-accuracy automatic annotation a...

Cardio.AI®

AI-powered platform for high-accuracy automatic annotation and interpretation of long ECG records.

Founded 2015 Latvia Latvia 11-50 employees Health Care, Information Technology +1

General Information

Company Name Cardio.AI®
Founded Year 2015
Location Latvia Latvia
Employees 11-50
Industries Health Care, Information Technology, Medical Devices
Social

BounceWatch is an independent company data service, not affiliated with Cardio.AI®. To contact Cardio.AI®, visit cardio.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cardio.AI® compare?

A PDF of Cardio.AI® and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cardio.AI® soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Cardio.AI®

XOresearch is a Latvia-based startup that has been operating since 2015. The company has developed a groundbreaking product named CardioAI, an AI-powered platform for high accuracy automatic annotation and interpretation of long and short ECG records. This proprietary software medical device utilizes deep learning technology to rapidly and accurately process ECG data, reducing the processing time for a single 24-hour ECG to about 30 seconds. This feature enables real-time monitoring and analysis of patients with heart conditions, offering physicians and caregivers an efficient tool to manage chronic conditions and potentially reduce non-essential hospitalizations. CardioAI is a feature-rich productivity tool designed to accelerate the interpretation of electrocardiograms, especially beneficial for prolonged or constant cardiac monitoring. It allows for better health surveillance in remote, difficult, or dangerous locations, providing accurate near real-time processing for unprecedented medical support. The software can be seamlessly integrated into an EHR system or incorporated into a mobile health device, making it adaptable to various business requirements. Notably, XOresearch takes data privacy seriously and their API does not accept any personal data with the signal, with reports modified on the client's side to add sensitive information. XOresearch operates at the intersection of healthcare and information technology industries, addressing a critical need for efficient cardiac monitoring and analysis. Although there is no available information about their latest investment or investors, the innovative nature of CardioAI and its potential to revolutionize cardiac care make XOresearch an intriguing prospect for venture capital firms seeking investment opportunities in the healthcare technology sector.

Business keywords: AI-powered platform, deep learning technology, ECG interpretation, medical device software, real-time monitoring, cardiac conditions management, EHR integration, remote health surveillance, API implementation, data privacy, healthcare analytics, mobile health devices, artificial intelligence in healthcare, data processing

No funding data available for Cardio.AI® yet.

Cardio.AI® Alternatives & Competitors

View All Alternatives
Cardio.AI® vs
NimbleHeart
NimbleHeart United States

NimbleHeart Physiotrace Smart is the FDA-approved wearable and easily reusable Exercise ECG Monitor...

Seed
7 employees
Health Care, Health and Wellness
Cardio.AI® vs
Walkky
Walkky United States

AI Platform for Cardiovascular Diagnosis

Non Equity Assistance
7 employees
Analytics, Health Care
Cardio.AI® vs
CardioComm Solutions Inc.
CardioComm Solutions Inc. Canada

CardioComm Solutions is a global provider of hospital, physician and consumer device and ECG softwa...

Post-IPO Debt
12 employees
Health Care, Information Technology
View all alternatives

FAQ About Cardio.AI®

AI-powered platform for high-accuracy automatic annotation and interpretation of long ECG records.
Cardio.AI® was founded in 2015.
Cardio.AI® is headquartered in Latvia.
Cardio.AI® operates in Health Care, Information Technology and Medical Devices. Its work centres on AI-powered platform, deep learning technology, ECG interpretation and medical device software.
Cardio.AI® has approximately 11-50 employees.
Top alternatives and competitors to Cardio.AI® include NimbleHeart, Walkky, CardioComm Solutions Inc., 山东优加利信息科技有限公司, MEZOO. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cardio.AI® and NimbleHeart are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cardio.AI®, https://bouncewatch.com/company/xoresearch, updated 19 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout